The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 is a strategic platform for discussion and collaboration among decision makers, researchers…
The growing global demand for cell and gene therapies (CGTs) is resulting in a manufacturing paradigm shift, reflecting the need…
With the approval date for Bristol Myers Squibb’s (BMS) schizophrenia drug KarXT (xanomeline-trospium) looming, prodrugs – medications that start as…
Astria Therapeutics has selected Ypsomed’s Ypsomate autoinjector as its partner for the administration of STAR-0215 for the treatment of hereditary…
US-based Leap Consulting Group has launched a practice aimed at guiding Clinical Laboratory Improvement Amendments-certified labs (CLIA) in adhering to…
During a session at the 2024 Alzheimer’s Association International Conference (AAIC), which concludes today, Ralph Carmona shared his experience of…
Gene therapy research is expensive. Biotechs invest millions of dollars in early research to develop therapies for conditions that might…
With the 2024 edition of the Alzheimer's Association International Conference (AAIC) underway in Philadelphia until 1 August, research into approaches…
Frameworks for environmental, social, and governance (ESG) reporting across sectors have long been focused on environmental sustainability, with plans that…
US-based 2seventy bio has completed an asset purchase agreement (APA) to divest its haemophilia A candidate to Novo Nordisk. 2seventy…